Previous 10 | Next 10 |
2024-06-09 16:23:25 ET Read the full article on Seeking Alpha For further details see: Stocks with the highest and lowest liquidity - Goldman Sachs
TORONTO, ON / ACCESSWIRE / May 30, 2024 / Cerrado Gold Inc. (TSX.V:CERT)(OTCQX:CRDOF) (" Cerrado " or the " Company ") is providing this update on the status of the cease trade order (the " CTO ") imposed on May 7, 2024 by its principal regulator, the Ontario Securities Commission (the " OSC "...
RADNOR, Pa., May 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, has appointed Rona Anhalt as Chief Human Resources Officer and Daniel Corcoran as General Counsel. "Rona and Daniel are leaders in their fields. They have ...
2024-05-16 18:36:07 ET Summary Absci Corporation, an AI-driven drug discovery company, has seen its share price plummet after its IPO in July 2021. Nearly all AI-driven drug discovery companies have struggled with overall share price performance since IPO. Absci's stock has be...
2024-05-16 08:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
TORONTO, ON / ACCESSWIRE / May 15, 2024 / Cerrado Gold Inc. (TSX.V:CERT)(OTCQX:CRDOF) (" Cerrado " or the " Company ") is providing an update on the status of the cease trade order (the " CTO ") imposed on May 7, 2024, the Ontario Securities Commission (the " OSC "), under National Policy 11-2...
TORONTO, ON / ACCESSWIRE / May 8, 2024 / Cerrado Gold Inc. (TSXV:CERT)(OTCQX:CRDOF) (" Cerrado " or the " Company ") announces that the Ontario Securities Commission (the " OSC ") has issued a failure to file cease trade order (" FFCTO ") prohibiting the trading by any person of any securities...
2024-05-08 03:56:05 ET Certara, Inc. (CERT) Q1 2024 Earnings Conference Call May 7, 2024 17:00 ET Company Participants David Deuchler - Investor Relations William Feehery - Chief Executive Officer John Gallagher - Chief Financial Officer Conference Call Par...
2024-05-07 18:06:12 ET More on Certara Certara Inc. (CERT) Q4 2023 Earnings Call Transcript Certara Q1 2024 Earnings Preview R1 RCM, Health Catalyst downgraded as KeyBanc reviews health-tech space Seeking Alpha’s Quant Rating on Certara Histori...
PRINCETON, N.J., May 07, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the first quarter of fiscal year 2024. First Quarter Highlights: Revenue was $96.7 million, compared to $90.3 million in t...
News, Short Squeeze, Breakout and More Instantly...
Q2 Production of 16,255 Gold Equivalent Ounces ("GEO") vs 11,204 GEO in Q1, 2024. High-Grade ore from Calandrias Norte and continued ramp-up at Heap leach operations are supporting strong quarterly production. MDN 43-101 Preliminary Economic Assessment and Updated Mineral Resource E...
2024-07-16 14:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Combined organization brings broader predictive capabilities to drug discovery at scale Reiterates full year 2024 guidance RADNOR, Pa., July 09, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced it has signed...